Also confirmed in Asia such as Malaysia
viewer
A case of infection with the strain Corona 19, which is up to 70% stronger than the existing novel coronavirus infection (Corona 19), has also been confirmed in France.
According to AFP and Reuters on the 25th (local time), the French Ministry of Health said that “a man who returned from living in London, England was confirmed to be infected.” This French man was tested two days after returning from London on the 19th and is currently in quarantine.
On the 24th of the previous day, a variant of Corona 19 infection occurred in Germany. The German Ministry of Health in Baden-Wurttemberg said a woman who recently arrived from London, UK, has been confirmed to have been infected with the coronavirus strain. Corona 19, the first variant that first appeared in southeastern England, at the end of September, was found to be up to 70% stronger than the existing virus.
As the number of cases of corona 19 infection outside the UK increases, there are concerns that the ban on entry from the UK is too late. With the spread of Corona 19 in the UK earlier, about 50 countries including Italy and Germany, as well as Hong Kong, Iran and Israel, stopped flights, trains, and cargo transportation from the UK and took self-quarantine measures against those who recently visited the UK. Etc. In the U.S., Delta Air Lines, Virgin Atlantic and British Airways have taken various measures to prevent the spread of the variant COVID-19, such as requiring only passengers who have tested negative for Corona 19 to board flights to New York at the request of New York Governor Andrew Cuomo. However, variant Corona 19 has already been confirmed in Denmark, Belgium, the Netherlands, Australia, Italy, Japan, Singapore and Malaysia.
As the spread of the variant Corona 19 continued and doubts about the effectiveness of the vaccine were raised, Pfizer, Bioentech, and Moderna began to verify the efficacy of their own vaccine against the variant virus. Pfizer said it is collecting data by taking blood samples from people with COVID-19 immunity to verify the vaccine immune response to the variant virus. Ur Shahin, CEO of Bioentech, who co-developed the vaccine with Pfizer, also said at a press conference, “Scientifically, the immune response of this vaccine is likely to act on the virus strain.” He added that the study and data collection will be conducted for about two weeks to obtain definite results. CEO Shahin explained that in the case of a variant virus, only 9 out of 1,270 amino acids have been mutated. “It means that 99% of the protein is still the same.” “Technically, we can provide a new vaccine within six weeks,” he emphasized.
Modena has also started testing a variant virus. According to Forbes, according to the data available to date in the statement, Modena said, “The immunity created by Modena or vaccines will protect against a recent virus strain in the UK.” “Additional over the next few weeks to confirm this expectation. We plan to conduct an experiment.”
Dr. Assisi Ja, dean of Brown University’s School of Public Health, told CNN that he expects the two vaccines to be effective against corona19 strain. “We are starting to find data that some monoclonal antibodies continue to work against this new strain,” he said. “So we expect the vaccine to continue to be effective.”
/ Kim Yeon Haja [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >